MONEY

Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET

Tomas Kauer - ModeratorTomas Kauer - Moderator
Oct 24, 2024 - 08:00
Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET
Read More

Tags:

Previous Article

Mother sues AI chatbot company Character.AI, Google over son's suicide

Next Article

GRUPO COMERCIAL CHEDRAUI, S.A.B. DE C.V. THIRD QUARTER 2024 RESULTS

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Stocks shine, Treasury yields rise as rate cut stokes risk appetite

Stocks shine, Treasury yields rise as rate cut stokes r...

Tomas Kauer - Mode... Sep 20, 2024

Exclusive-US keeps missile system in Philippines as China tensions rise, tests wartime deployment

Exclusive-US keeps missile system in Philippines as Chi...

Tomas Kauer - Mode... Sep 19, 2024

Ambetter of Illinois Expands Health Insurance Offering to 25 Counties Statewide

Ambetter of Illinois Expands Health Insurance Offering ...

Tomas Kauer - Mode... Oct 3, 2024